B C Finzel - JoVE Visualize

Showing results (21-30 of 28) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 28 results.

The Journal of Biological Chemistry|October 15, 1990

The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolutionD R Holland, L L Clancy, S W Muchmore, et al.

Journal of Molecular Biology|July 20, 1992

Crystallization of the NAD-dependent malic enzyme from the parasitic nematode Ascaris suumL L Clancy, G S Rao, B C Finzel, et al.

Acta Crystallographica. Section D, Biological Crystallography|July 1, 1993

Crystallographic analyses of an active HIV-1 ribonuclease H domain show structural features that distinguish it from the inactive formD Chattopadhyay, B C Finzel, S H Munson, et al.

Journal of Medicinal Chemistry|May 26, 1995

Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitorsK R Romines, K D Watenpaugh, P K Tomich, et al.

Protein Science : a Publication of the Protein Society|October 29, 1998

Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivityB C Finzel, E T Baldwin, G L Bryant, et al.

Protein Expression and Purification|January 12, 1999

Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterizationA G Tomasselli, D J Paddock, K A Curry, et al.

Structure (London, England : 1993)|August 4, 1998

Cation binding to the integrin CD11b I domain and activation model assessmentE T Baldwin, R W Sarver, G L Bryant, et al.

Journal of Medicinal Chemistry|November 8, 1996

Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitorsS Thaisrivongs, D L Romero, R A Tommasi, et al.

Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 28 results.

The Journal of Biological Chemistry|October 15, 1990

The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolutionD R Holland, L L Clancy, S W Muchmore, et al.

Journal of Molecular Biology|July 20, 1992

Crystallization of the NAD-dependent malic enzyme from the parasitic nematode Ascaris suumL L Clancy, G S Rao, B C Finzel, et al.

Acta Crystallographica. Section D, Biological Crystallography|July 1, 1993

Crystallographic analyses of an active HIV-1 ribonuclease H domain show structural features that distinguish it from the inactive formD Chattopadhyay, B C Finzel, S H Munson, et al.

Journal of Medicinal Chemistry|May 26, 1995

Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitorsK R Romines, K D Watenpaugh, P K Tomich, et al.

Protein Science : a Publication of the Protein Society|October 29, 1998

Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivityB C Finzel, E T Baldwin, G L Bryant, et al.

Protein Expression and Purification|January 12, 1999

Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterizationA G Tomasselli, D J Paddock, K A Curry, et al.

Structure (London, England : 1993)|August 4, 1998

Cation binding to the integrin CD11b I domain and activation model assessmentE T Baldwin, R W Sarver, G L Bryant, et al.

Journal of Medicinal Chemistry|November 8, 1996

Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitorsS Thaisrivongs, D L Romero, R A Tommasi, et al.

Pageof 3